The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Asthma Management Products-Global Market Insights and Sales Trends 2024
Synopsis
Asthma is a chronic disease, which cannot be cured only appropriate management is possible to control the disease. Asthma targets airways of the lungs causing it to inflame, swallow and tightens the airway of the lungs, causing respiratory tract infection and causing symptoms such as coughing, shortness of breath, tightness, and wheezing. The symptoms of the asthma are related to physical activity, even healthy people suffer from asthma symptoms during vigorous exercise. This type of asthma is called exercise-induced bronchoconstriction (EIB). This type of asthma is controlled and the symptoms are kept under control by developing a management plan by a physician. People with family history of asthma are more prone to this illness and develop allergies frequently. This type of asthma is called allergic asthma. The allergies/asthma due to toxic fumes, gases, dust during the occupation/work in known as occupational asthma. Childhood asthma effects millions of children and is developed in mainly during first five years of life.
The global Asthma Management Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Management Products in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy, Drug Stores and Online Pharmacy, are propelling Asthma Management Products market. Corticosteroids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bronchodilators segment is estimated at % CAGR for the next seven-year period.
Asthma is diagnosed by looking after patient medical history and performing breathing tests, this test helps to measure the amount of air the lungs can hold and examines asthma severity. The medication to manage asthma symptoms are taken daily and contains inhaled corticosteroids such as ciclesonide, budesonide, flunisolide and others. Short acting beta agonist are prescribed for quick relief. The inhaler contains beta blockers and inhaled corticosteroid. Leukotriene modifiers are prescribed for asthma as oral medication. The people suffering from symptoms suffer from respiratory infections such as influenza and pneumonia.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asthma Management Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asthma Management Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asthma Management Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Management Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asthma Management Products covered in this report include Teva Pharmaceutical Industries, AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GE Healthcare, Merck, Baxter, GlaxoSmithKline and Sanofi-Aventis, etc.
The global Asthma Management Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical Industries
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GE Healthcare
Merck
Baxter
GlaxoSmithKline
Sanofi-Aventis
Novartis
Global Asthma Management Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asthma Management Products market, Segment by Type:
Corticosteroids
Bronchodilators
Others
Global Asthma Management Products market, by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asthma Management Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asthma Management Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Asthma is a chronic disease, which cannot be cured only appropriate management is possible to control the disease. Asthma targets airways of the lungs causing it to inflame, swallow and tightens the airway of the lungs, causing respiratory tract infection and causing symptoms such as coughing, shortness of breath, tightness, and wheezing. The symptoms of the asthma are related to physical activity, even healthy people suffer from asthma symptoms during vigorous exercise. This type of asthma is called exercise-induced bronchoconstriction (EIB). This type of asthma is controlled and the symptoms are kept under control by developing a management plan by a physician. People with family history of asthma are more prone to this illness and develop allergies frequently. This type of asthma is called allergic asthma. The allergies/asthma due to toxic fumes, gases, dust during the occupation/work in known as occupational asthma. Childhood asthma effects millions of children and is developed in mainly during first five years of life.
The global Asthma Management Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Management Products in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy, Drug Stores and Online Pharmacy, are propelling Asthma Management Products market. Corticosteroids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bronchodilators segment is estimated at % CAGR for the next seven-year period.
Asthma is diagnosed by looking after patient medical history and performing breathing tests, this test helps to measure the amount of air the lungs can hold and examines asthma severity. The medication to manage asthma symptoms are taken daily and contains inhaled corticosteroids such as ciclesonide, budesonide, flunisolide and others. Short acting beta agonist are prescribed for quick relief. The inhaler contains beta blockers and inhaled corticosteroid. Leukotriene modifiers are prescribed for asthma as oral medication. The people suffering from symptoms suffer from respiratory infections such as influenza and pneumonia.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asthma Management Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asthma Management Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asthma Management Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Management Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asthma Management Products covered in this report include Teva Pharmaceutical Industries, AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GE Healthcare, Merck, Baxter, GlaxoSmithKline and Sanofi-Aventis, etc.
The global Asthma Management Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical Industries
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GE Healthcare
Merck
Baxter
GlaxoSmithKline
Sanofi-Aventis
Novartis
Global Asthma Management Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asthma Management Products market, Segment by Type:
Corticosteroids
Bronchodilators
Others
Global Asthma Management Products market, by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asthma Management Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asthma Management Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Asthma Management Products Market Overview
1.1 Asthma Management Products Product Overview
1.2 Asthma Management Products Market Segment by Type
1.2.1 Corticosteroids
1.2.2 Bronchodilators
1.2.3 Others
1.3 Global Asthma Management Products Market Size by Type
1.3.1 Global Asthma Management Products Market Size Overview by Type (2018-2029)
1.3.2 Global Asthma Management Products Historic Market Size Review by Type (2018-2023)
1.3.3 Global Asthma Management Products Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Asthma Management Products Sales Breakdown by Type (2018-2023)
1.4.2 Europe Asthma Management Products Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Asthma Management Products Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Asthma Management Products Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Asthma Management Products Sales Breakdown by Type (2018-2023)
2 Global Asthma Management Products Market Competition by Company
2.1 Global Top Players by Asthma Management Products Sales (2018-2023)
2.2 Global Top Players by Asthma Management Products Revenue (2018-2023)
2.3 Global Top Players by Asthma Management Products Price (2018-2023)
2.4 Global Top Manufacturers Asthma Management Products Manufacturing Base Distribution, Sales Area, Product Type
2.5 Asthma Management Products Market Competitive Situation and Trends
2.5.1 Asthma Management Products Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Asthma Management Products Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Management Products as of 2022)
2.7 Date of Key Manufacturers Enter into Asthma Management Products Market
2.8 Key Manufacturers Asthma Management Products Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Asthma Management Products Status and Outlook by Region
3.1 Global Asthma Management Products Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Asthma Management Products Historic Market Size by Region
3.2.1 Global Asthma Management Products Sales in Volume by Region (2018-2023)
3.2.2 Global Asthma Management Products Sales in Value by Region (2018-2023)
3.2.3 Global Asthma Management Products Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Asthma Management Products Forecasted Market Size by Region
3.3.1 Global Asthma Management Products Sales in Volume by Region (2024-2029)
3.3.2 Global Asthma Management Products Sales in Value by Region (2024-2029)
3.3.3 Global Asthma Management Products Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Asthma Management Products by Application
4.1 Asthma Management Products Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Drug Stores
4.1.4 Online Pharmacy
4.2 Global Asthma Management Products Market Size by Application
4.2.1 Global Asthma Management Products Market Size Overview by Application (2018-2029)
4.2.2 Global Asthma Management Products Historic Market Size Review by Application (2018-2023)
4.2.3 Global Asthma Management Products Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Asthma Management Products Sales Breakdown by Application (2018-2023)
4.3.2 Europe Asthma Management Products Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Asthma Management Products Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Asthma Management Products Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Asthma Management Products Sales Breakdown by Application (2018-2023)
5 North America Asthma Management Products by Country
5.1 North America Asthma Management Products Historic Market Size by Country
5.1.1 North America Asthma Management Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Asthma Management Products Sales in Volume by Country (2018-2023)
5.1.3 North America Asthma Management Products Sales in Value by Country (2018-2023)
5.2 North America Asthma Management Products Forecasted Market Size by Country
5.2.1 North America Asthma Management Products Sales in Volume by Country (2024-2029)
5.2.2 North America Asthma Management Products Sales in Value by Country (2024-2029)
6 Europe Asthma Management Products by Country
6.1 Europe Asthma Management Products Historic Market Size by Country
6.1.1 Europe Asthma Management Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Asthma Management Products Sales in Volume by Country (2018-2023)
6.1.3 Europe Asthma Management Products Sales in Value by Country (2018-2023)
6.2 Europe Asthma Management Products Forecasted Market Size by Country
6.2.1 Europe Asthma Management Products Sales in Volume by Country (2024-2029)
6.2.2 Europe Asthma Management Products Sales in Value by Country (2024-2029)
7 Asia-Pacific Asthma Management Products by Region
7.1 Asia-Pacific Asthma Management Products Historic Market Size by Region
7.1.1 Asia-Pacific Asthma Management Products Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Asthma Management Products Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Asthma Management Products Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Asthma Management Products Forecasted Market Size by Region
7.2.1 Asia-Pacific Asthma Management Products Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Asthma Management Products Sales in Value by Region (2024-2029)
8 Latin America Asthma Management Products by Country
8.1 Latin America Asthma Management Products Historic Market Size by Country
8.1.1 Latin America Asthma Management Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Asthma Management Products Sales in Volume by Country (2018-2023)
8.1.3 Latin America Asthma Management Products Sales in Value by Country (2018-2023)
8.2 Latin America Asthma Management Products Forecasted Market Size by Country
8.2.1 Latin America Asthma Management Products Sales in Volume by Country (2024-2029)
8.2.2 Latin America Asthma Management Products Sales in Value by Country (2024-2029)
9 Middle East and Africa Asthma Management Products by Country
9.1 Middle East and Africa Asthma Management Products Historic Market Size by Country
9.1.1 Middle East and Africa Asthma Management Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Asthma Management Products Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Asthma Management Products Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Asthma Management Products Forecasted Market Size by Country
9.2.1 Middle East and Africa Asthma Management Products Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Asthma Management Products Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Company Information
10.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Pharmaceutical Industries Asthma Management Products Products Offered
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Asthma Management Products Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Asthma Management Products Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Company Information
10.4.2 F. Hoffmann-La Roche Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.4.4 F. Hoffmann-La Roche Asthma Management Products Products Offered
10.4.5 F. Hoffmann-La Roche Recent Development
10.5 GE Healthcare
10.5.1 GE Healthcare Company Information
10.5.2 GE Healthcare Introduction and Business Overview
10.5.3 GE Healthcare Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GE Healthcare Asthma Management Products Products Offered
10.5.5 GE Healthcare Recent Development
10.6 Merck
10.6.1 Merck Company Information
10.6.2 Merck Introduction and Business Overview
10.6.3 Merck Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Merck Asthma Management Products Products Offered
10.6.5 Merck Recent Development
10.7 Baxter
10.7.1 Baxter Company Information
10.7.2 Baxter Introduction and Business Overview
10.7.3 Baxter Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Baxter Asthma Management Products Products Offered
10.7.5 Baxter Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GlaxoSmithKline Asthma Management Products Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 Sanofi-Aventis
10.9.1 Sanofi-Aventis Company Information
10.9.2 Sanofi-Aventis Introduction and Business Overview
10.9.3 Sanofi-Aventis Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sanofi-Aventis Asthma Management Products Products Offered
10.9.5 Sanofi-Aventis Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Asthma Management Products Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis Asthma Management Products Products Offered
10.10.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Asthma Management Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Asthma Management Products Industrial Chain Analysis
11.4 Asthma Management Products Market Dynamics
11.4.1 Asthma Management Products Industry Trends
11.4.2 Asthma Management Products Market Drivers
11.4.3 Asthma Management Products Market Challenges
11.4.4 Asthma Management Products Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Asthma Management Products Distributors
12.3 Asthma Management Products Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
